Institution profile

CASAクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01E2508011 +4

Location

Prefecture
Osaka
Address
大阪市中央区西心斎橋一丁目5番5号アーバンBLD心斎橋7階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 一般社団法人 細胞免疫学研究会 認定再生医療等委員会

Public score

62.1/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 62.1
Public score →100

Registered technologies (5)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
慢性疼痛に対する自己脂肪組織由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
変形性関節症に対する自己脂肪組織由来幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
慢性疼痛に対する自己脂肪組織由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
変形性関節症に対する自己脂肪組織由来幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
がんの治療と予防を目的としたNK細胞を用いたアンチエイジング療法NK and immune cellsClass III
がんの治療と予防を目的としたT細胞/γδNKT細胞治療NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
変形性関節症に対する自己脂肪組織由来幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 一般社団法人 細胞免疫学研究会 認定再生医療等委員会

Public document number

  • 01E2508011
  • 01E2508012
  • 01E2508013
  • 01E2508009
  • 01E2508010
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Class IIJSCSF再生医療等委員会01E2508011
変形性関節症に対する自己脂肪組織由来幹細胞を用いた治療Class IIJSCSF再生医療等委員会01E2508012
慢性疼痛に対する自己脂肪組織由来幹細胞による治療Class IIJSCSF再生医療等委員会01E2508013
がんの治療と予防を目的としたNK細胞を用いたアンチエイジング療法Class III一般社団法人 細胞免疫学研究会 認定再生医療等委員会01E2508009
がんの治療と予防を目的としたT細胞/γδNKT細胞治療Class III一般社団法人 細胞免疫学研究会 認定再生医療等委員会01E2508010

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor